Jun 06, 2022 / 09:40PM GMT
John Charles Kreger - William Blair & Company L.L.C., Research Division - Interim Director of Research
Our next section is West Pharmaceutical Services. I'm John Kreger, the Interim Director of Research at William Blair, and I'm also the analyst that covers the stock. Thank you all for coming. This is the last session of the day in this room, which just means when we get to Q&A after the presentation, we'll just stay here. So that's the one thing I will flag for you guys. By way of disclosures, please feel free to check williamblair.com for any conflicts.
We've got doing the presentation, the CEO, Eric Green. Thanks, Eric, for the time. We also have Bernard Birkett, CFO; and also Quintin Lai, Head of IR. So they will certainly take part in Q&A as.
So we're thrilled to have West back. They've been -- I think we've covered you guys for maybe 5 years. It's been a fantastic name to cover. If you don't know it, Eric will walk through the presentation, but it's a really cool kind of biologic containment player, a fairly niche application, but they've done a really great job in a
West Pharmaceutical Services Inc at William Blair Growth Stock Conference Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers